17 results
8-K
EX-2.1
MACA
Moringa Acquisition Corp - Ordinary Shares
3 Apr 24
Entry into a Material Definitive Agreement
11:22am
in an investment infusion in any Group Company, with one or more investors acquiring a minority percentage of equity of such Group Company, provided
8-K
EX-2.1
MACA
Moringa Acquisition Corp - Ordinary Shares
26 Feb 24
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
5:29pm
that results in an investment infusion in any Group Company, with one or more investors acquiring a minority percentage of equity of such Group Company
PRER14A
cllc03l
24 Jul 23
Preliminary revised proxy
4:45pm
PRE 14A
zxenbye2
15 Dec 22
Preliminary proxy
5:18pm
10-K
b3h6talm7as54
31 Mar 21
Annual report
5:15pm
10-K
EX-4.5
ah0wxw36go7
31 Mar 21
Annual report
5:15pm
424B4
sf11o1fyq fc5siw
17 Feb 21
Prospectus supplement with pricing info
11:53am
S-1
wud5dirov8t8vj
1 Feb 21
IPO registration
4:12pm
DRS
stmouq3pt9j5kusnf5n
22 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next